January 13, 2023 — A change to Medicare policy surrounding heart transplant may lead to increased inequities in access to transplant for patients with heart failure, a Michigan Medicine study finds ...
Ventricular Assist Devices (VAD)
This channel includes news and new technology innovations for ventricular assist devices (VAD). VADs are a type of mechanical hemodynamic support device that helps increase blood flow in people who have ventricles that are not work properly due to heart failure, cardiogenic shock, cardiomyopathy or myocardial infarction. Most often these devices support the left ventricle, so they are often referred to as left ventricular assist devices (LVAD). VADS come in two types, surgically implanted, usually as a bridge to heart transplant, and percutanenous catheter-based pumps used for temporary hemodynamic support. Examples of temporary percutaneous pumps include the Impella and TandemHeart devices.
-
-
November 1, 2022 — Abiomed announced that Impella RP Flex with SmartAssist has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA), the FDA’s highest level of approval, as safe ...
-
October 18, 2022 — The U.S. Food and Drug Administration (FDA) is providing updates to the FDA website to include information on recent recalls conducted by Medtronic. Medtronic announced that a ...
-
September 17, 2022 — Results of a new per-protocol analysis of the ST-segment Elevation Myocardial Infarction Door-To-Unload (STEMI DTU) pilot trial data show significantly reduced infarct size in ...
February 21, 2024 — Ochsner Children's Hospital, ranked among the top hospitals in the nation for pediatric cardiology a ...
February 21, 2024
October 31, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop ...
October 31, 2023
October 5, 2023 — A newly-issued "Scientific Statement on Durable Mechanical Circulatory Support" in the October issue ...
October 04, 2023
September 15, 2023 — A team of interventional cardiologists from Henry Ford Health’s Center for Structural Heart Disease ...
September 15, 2023
July 14, 2023 — In recent years, transcatheter intervention techniques have emerged as a promising alternative for the ...
July 14, 2023
June 7, 2023 — Magenta Medical Ltd. has announced the initiation of its FDA-approved Early Feasibility Study with the ...
June 07, 2023
March 1, 2023 — Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, today ...
March 01, 2023
February 24, 2023
January 13, 2023 — A change to Medicare policy surrounding heart transplant may lead to increased inequities in access ...
January 13, 2023
November 2, 2022 — For decades, left ventricular-assist devices (LVADs) have extended the lives of people whose hearts ...
November 02, 2022
November 1, 2022 — Abiomed announced that Impella RP Flex with SmartAssist has received U.S. Food and Drug ...
November 01, 2022
October 12, 2022 — Following the recent European Society of Cardiology (ESC) Congress in Barcelona, Spain last month, ...
October 12, 2022
September 17, 2022 — Results of a new per-protocol analysis of the ST-segment Elevation Myocardial Infarction Door-To ...
September 17, 2022
August 25, 2022 — The U.S. Food and Drug Administration (FDA) issued a statement that Medtronic, Inc. is recalling Heart ...
August 25, 2022
August 5, 2022 — Black people and women with severe heart failure who might be good candidates for surgery to implant a ...
August 05, 2022© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now